Travel Medicine
Authors: Brian S. Schwartz, Regina C. LaRocque, Edward T. Ryan
Journal: Annals of Internal Medicine (2012)

In the Clinic5 June 2012Travel MedicineBrian S. Schwartz, MD, Regina C. LaRocque, MD, MPH, Edward T. Ryan, MD, Deborah Cotton, MD, MPH, Darren Taichman, MD, PhD, and Sankey Williams, MDBrian S. Schwartz, MDSearch for more papers by this author, Regina C. LaRocque, MD, MPHSearch for more papers by this author, Edward T. Ryan, MDSearch for more papers by this author, Deborah Cotton, MD, MPHSearch for more papers by this author, Darren Taichman, MD, PhDSearch for more papers by this author, and Sankey Williams, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-156-11-201206050-01006 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Primary care physicians are frequent sources of health advice for U.S. international travelers (1, 2). To properly prepare travelers, health care providers need to be familiar with destination-specific disease risks, travel and routine vaccines, chemoprophylaxis regimens, and self-treatment regimens for infectious and noninfectious illnesses. In addition, ill returning travelers may seek care in primary care settings, and these providers need to be appropriately prepared. Of note, the Centers for Disease Control and Prevention (CDC) maintains a Web site focused on travelers' health (www.cdc.gov/travel/) and regularly updates a publication entitled CDC Health Information for International Travel (i.e., The Yellow Book) (3). ...References1. Office of Travel and Tourism Industries 2010 Outbound Analysis. Office of Travel and Tourism Industries, U.S. Department of Commerce 2011. Google Scholar2. LaRocque RC, Rao SR, Tsibris A, Lawton T, Barry MA, Marano N, et al. Pretravel health advice-seeking behavior among US international travelers departing from Boston Logan International Airport. J Travel Med. 2010;17:387-91. [PMID: 21050318] Google Scholar3. Bacaner N, Stauffer B, Boulware DR, Walker PF, Keystone JS. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA. 2004; 16;291:2856-64. [PMID: 15199037] Google Scholar4. Lapostolle F, Surget V, Borron SW, Desmaizières M, Sordelet D, Lapandry C, et al. Severe pulmonary embolism associated with air travel. N Engl J Med. 2001;345:779-83. [PMID: 11556296] Google Scholar5. Chandra D, Parisini E, Mozaffarian D. Meta-analysis: travel and risk for venous thromboembolism. Ann Intern Med. 2009;151:180-90. [PMID: 19581633] Google Scholar6. Kuipers S, Cannegieter SC, Middeldorp S, Robyn L, Büller HR, Rosendaal FR. The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations. PLoS Med. 2007;4:e290. [PMID: 17896862] Google Scholar7. Watson HG, Baglin TP. Guidelines on travel-related venous thrombosis. Br J Haematol. 2011;152:31-4. [PMID: 21083651] Google Scholar8. Clarke M, Hopewell S, Juszczak E, Eisinga A, Kjeldstr¿m M. Compression stockings for preventing deep vein thrombosis in airline passengers. Cochrane Database Syst Rev. 2006:CD004002. [PMID: 16625594] Google Scholar9. Cesarone MR, Belcaro G, Nicolaides AN, Incandela L, De S, Geroulakos G, et al. Venous thrombosis from air travel: the LONFLIT3 study-prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial. Angiology. 2002;53:1-6. [PMID: 11863301] Google Scholar10. Ward KA, Armstrong P, McAnulty JM, Iwasenko JM, Dwyer DE. Outbreaks of pandemic (H1N1) 2009 and seasonal influenza A (H3N2) on cruise ship. Emerging infectious diseases. 2010;16(11):1731-7. Google Scholar11. Beyrer K, Lai S, Dreesman J, Lee JV, Joseph C, Harrison T, et al. Legionnaires' disease outbreak associated with a cruise liner, August 2003: epidemiological and microbiological findings. Epidemiol Infect. 2007;135:802-10. [PMID: 17109773] Google Scholar12. Wikswo ME, Cortes J, Hall AJ, Vaughan G, Howard C, Gregoricus N, et al. Disease transmission and passenger behaviors during a high morbidity Norovirus outbreak on a cruise ship, January 2009. Clin Infect Dis. 2011;52:1116-22. [PMID: 21429864] Google Scholar13. Gahlinger PM. Cabin location and the likelihood of motion sickness in cruise ship passengers. J Travel Med. 2000;7: 120-4. [PMID: 11179940] Google Scholar14. Shlim DR. Looking for evidence that personal hygiene precautions prevent traveler's diarrhea. Clin Infect Dis. 2005;41 Suppl 8:S531-5. [PMID: 16267714] Google Scholar15. Lillie TH, Schreck CE, Rahe AJ. Effectiveness of personal protection against mosquitoes in Alaska. J Med Entomol. 1988;25:475-8. [PMID: 2905009] Google Scholar16. Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med. 2002;347:13-8. [PMID: 12097535] Google Scholar17. Gautret P, Schwartz E, Shaw M, Soula G, Gazin P, Delmont J, et al; GeoSentinel Surveillance Network. Animal-associated injuries and related diseases among returned travellers: a review of the GeoSentinel Surveillance Network. Vaccine. 2007;25:2656-63. [PMID: 17234310] Google Scholar18. Death of U.S. citizens abroad by non-natural causes. U.S. Department of State; 2011. Accessed at http://travel.state.gov/law/family_issues/death/death_600.html Google Scholar19. Association for Safe International Road Travel: Know Before You Go. Association for Safe International Road Travel. Accessed at www.asirt.org/KnowBeforeYouGo/EducationAbroad/tabid/202/Default.aspx Google Scholar20. Bloch KE, Turk AJ, Maggiorini M, Hess T, Merz T, Bosch MM, et al. Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m. High Alt Med Biol. 2009;10:25-32. [PMID: 19326598] Google Scholar21. Sheffield PJ. Flying after diving guidelines: a review. Aviat Space Environ Med. 1990;61:1130-8. [PMID: 2285403] Google Scholar22. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis—United States, 2007. MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries / CDC. 2009;58(3):1-27. Google Scholar23. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, et al; GeoSentinel Surveillance Network. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006;354:119-30. [PMID: 16407507] Google Scholar24. Fraser A, Goldberg E, Acosta CJ, Paul M, Leibovici L. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev. 2007:CD001261. [PMID: 17636661] Google Scholar25. Fraser A, Paul M, Goldberg E, Acosta CJ, Leibovici L. Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Vaccine. 2007;25:7848-57. [PMID: 17928109] Google Scholar26. Kaltenböck A, Dubischar-Kastner K, Schuller E, Datla M, Klade CS, Kishore TS. Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age. Vaccine. 2010;28:834-9. [PMID: 19857447] Google Scholar27. Shin S, Desai SN, Sah BK, Clemens JD. Oral vaccines against cholera. Clin Infect Dis. 2011;52:1343-9. [PMID: 21498389] Google Scholar28. Centers for Disease Control and Prevention (CDC). Measles: United States, January-May 20, 2011. MMWR Morb Mortal Wkly Rep. 2011;60:666-8. [PMID: 21617634] Google Scholar29. Mali S, Tan KR, Arguin PM; Division of Parasitic Diseases and Malaria, Center for Global Health. Malaria surveillance-United States, 2009. MMWR Surveill Summ. 2011;60(3):1-15. [PMID: 21508921] Google Scholar30. Basnyat B, Gertsch JH, Johnson EW, Castro-Marin F, Inoue Y, Yeh C. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial. High Alt Med Biol. 2003;4:45-52. [PMID: 12713711] Google Scholar31. van Patot MC, Leadbetter G 3rd, Keyes LE, Maakestad KM, Olson S, Hackett PH.Prophylactic lowdose acetazolamide reduces the incidence and severity of acute mountain sickness. High Alt Med Biol. 2008;9: 289-93. [PMID: 19115912] Google Scholar32. Steffen R, van der Linde F, Gyr K, Schär M. Epidemiology of diarrhea in travelers. JAMA. 1983;249:1176-80. [PMID: 6823079] Google Scholar33. Greenwood Z, Black J, Weld L, O'Brien D, Leder K, Von Sonnenburg F, et al; GeoSentinel Surveillance Network. Gastrointestinal infection among international travelers globally. J Travel Med. 20 http://travel.state.gov/law/family_issues/death/death_600.html 08;15:221-8. [PMID: 18666921] Google Scholar34. DuPont HL, Jiang ZD, Okhuysen PC, Ericsson CD, de la Cabada FJ, Ke S, et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med. 2005;142:805-12. [PMID: 15897530] Google Scholar35. DuPont HL, Sullivan P, Evans DG, Pickering LK, Evans DJ Jr, Vollet JJ, et al. Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth). JAMA. 1980;243:237-41. [PMID: 6985681] Google Scholar36. DuPont HL, Ericsson CD, Johnson PC, Bitsura JA, DuPont MW, de la Cabada FJ. Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate. JAMA. 1987;257:1347-50. [PMID: 3820443] Google Scholar37. de dios Pozo-Olano J, Warram JH Jr, G—mez RG, Cavazos MG. Effect of a lactobacilli preparation on traveler's diarrhea. A randomized, double blind clinical trial. Gastroenterology. 1978;74:829-30. [PMID: 416989] Google Scholar38. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers. J Travel Med. 1997;4:41-43. [PMID: 9815476] Google Scholar39. Briand V, Buffet P, Genty S, Lacombe K, Godineau N, Salomon J, et al. Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study. Clin Infect Dis. 2006;43:1170-5. [PMID: 17029137] Google Scholar40. Jamieson AO, Zammit GK, Rosenberg RS, Davis JR, Walsh JK. Zolpidem reduces the sleep disturbance of jet lag. Sleep Med. 2001;2:423-30. [PMID: 14592392] Google Scholar41. Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002:CD001520. [PMID: 12076414] Google Scholar42. Wilson ME, Weld LH, Boggild A, Keystone JS, Kain KC, von Sonnenburg F, et al; GeoSentinel Surveillance Network. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis. 2007;44:1560-8. [PMID: 17516399] Google Scholar43. LLederman ER, Weld LH, Elyazar IR, von Sonnenburg F, Loutan L, Schwartz E, et al; GeoSentinel Surveillance Network. Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network. Int J Infect Dis. 2008;12:593-602. [PMID: 18343180] Google Scholar44. Swaminathan A, Torresi J, Schlagenhauf P, Thursky K, Wilder-Smith A, Connor BA, et al; GeoSentinel Network. A global study of pathogens and host risk factors associated with infectious gastrointestinal disease in returned international travellers. J Infect. 2009;59:19-27. [PMID: 19552961] Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byA challenging entanglement: health care providers’ perspectives on caring for ill and injured tourists on Cozumel Island, MexicoCare for the Health Care ProviderAn overview of travel-associated central nervous system infectious diseases: risk assessment, general considerations and future directions 5 June 2012Volume 156, Issue 11Page: ITC6-1KeywordsChemopreventionDiarrheaFeversMalariaMedical conditionsPregnancyRabiesTyphoidVaccines ePublished: 5 June 2012 Issue Published: 5 June 2012 Copyright & PermissionsCopyright © 2012 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...